Incisional hernia after liver transplantation: Risk factors, management strategies and long-term outcomes of a cohort study.


Journal

International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 25 02 2020
revised: 09 04 2020
accepted: 19 04 2020
pubmed: 27 4 2020
medline: 18 9 2020
entrez: 27 4 2020
Statut: ppublish

Résumé

Incisional hernias (IH) develop in up to 40% of liver transplant (LT) recipients and can contribute to considerable morbidity. A single center retrospective review of a prospectively maintained LT database was conducted to identify all patients diagnosed with IH after LT during a 13-year study period (2003-2015). Analyzed data included patient demographics, LT details, incidence and timing of IH, risk factors, management strategies and long-term outcomes. During the 13-year study period, IH was diagnosed in 16.7% (163/976) of LT recipients after a median of 19.6 months (range 6.7-49.5 months) from transplant surgery. Identified risk factors for developing IH included male gender (p < 0.001) while acute cellular rejection (ACR) was found to be negatively associated with the risk of developing IH (p = 0.014). Acute incarceration/strangulation was seen in 4 patients with IH while the remaining (n = 159) presented with non-emergent symptoms. Surgical repair was undertaken in 70/163 (43%) IH patients after medical optimization when possible (open repair 83%, mesh use 90%). IH recurrence rate was 14.3% (10/70) with comparable rates in no-mesh and with-mesh repairs (42.9% vs. 11.3%; p = 0.057) and open (15.8%) and laparoscopic (9.1%) approaches (p = 0.68). IH is a late complication following LT and male gender is a consistent predictive marker. Acute presentation is infrequent and elective repair can be planned in most patients allowing for risk factor optimization to ensure promising long-term outcomes.

Identifiants

pubmed: 32335240
pii: S1743-9191(20)30347-2
doi: 10.1016/j.ijsu.2020.04.048
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-153

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None declared.

Auteurs

Heidy Cos (H)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Ola Ahmed (O)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA. Electronic address: olaahmed@wustl.edu.

Sandra Garcia-Aroz (S)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Neeta Vachharajani (N)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Surendra Shenoy (S)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Jason R Wellen (JR)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Maria Mb Doyle (MM)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

William C Chapman (WC)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Adeel S Khan (AS)

Division of Transplantation, Department of Surgery, Washington University in St Louis, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH